A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis

INTRODUCTION: Osteoporosis is a serious condition affecting up to 50% of Indian postmenopausal women. Denosumab reduces bone resorption by targeting the receptor activator of nuclear factor-κB ligand. This study assessed the efficacy and safety of denosumab in Indian postmenopausal women with osteop...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitale, Shailesh, Thomas, Mathew, Rathi, Gaurav, Deshmukh, Vaishali, Kumar, Prasanna, Reddy, Sanjay, Shetty, Naresh, Kakar, Atul, Babhulkar, Sushrut, Mody, Bharat, Chacko, Jacob, Acharya, Sudeep, Joglekar, Sadhna, Halbe, Vipul, Kravitz, Barbara G., Waterhouse, Brian, Nino, Antonio J., Fitzpatrick, Lorraine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287760/
https://www.ncbi.nlm.nih.gov/pubmed/25593843
http://dx.doi.org/10.4103/2230-8210.146871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287760/
https://www.ncbi.nlm.nih.gov/pubmed/25593843
http://dx.doi.org/10.4103/2230-8210.146871

Ejemplares similares